RxDoctor Payments Data

Maria May, DO

Internal Medicine · Newark, OHNPI 1093256216

Payments from drug & device makers

$270in general payments, 2019–2025

Across 16 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$73
  • E.r. Squibb & Sons, L.L.C.$57
  • Dexcom, Inc.$42
  • Novo Nordisk$27
  • AbbVie$21
  • GSK$19
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$270100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$270 in reported general payments places this provider in the 55th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$204,647
Medicare patients
408
Services billed
6,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$143,748
EliquisApixaban112$126,387
JanuviaSitagliptin Phosphate67$78,646
JardianceEmpagliflozin28$47,414
TrulicityDulaglutide26$35,581
MounjaroTirzepatide34$34,900
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$18,969
Tresiba Flextouch U-100Insulin Degludec24$10,662
SymbicortBudesonide/Formoterol Fumarate20$8,461
Lantus SolostarInsulin Glargine,hum.Rec.Anlog60$6,862
Atorvastatin Calcium639$6,554
Levothyroxine Sodium568$5,218
Rosuvastatin Calcium312$4,716
Advair DiskusFluticasone Propion/Salmeterol21$3,980
Duloxetine Hcl101$3,837

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$27$143,74894 claims
PfizerEliquis$73$126,387112 claims
GSKTrelegy Ellipta$19$18,96918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Newark

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →